Skip to main content

Peer Review reports

From: Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

Original Submission
3 Nov 2010 Submitted Original manuscript
8 Nov 2010 Author responded Author comments - Fotios Loupakis
Resubmission - Version 2
8 Nov 2010 Submitted Manuscript version 2
8 Nov 2010 Author responded Author comments - Fotios Loupakis
Resubmission - Version 3
8 Nov 2010 Submitted Manuscript version 3
14 Apr 2011 Author responded Author comments - Fotios Loupakis
14 Feb 2011 Reviewed Reviewer Report - Chris Garrett
27 Feb 2011 Reviewed Reviewer Report - W. Charles Conway
Resubmission - Version 4
14 Apr 2011 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
10 Jun 2011 Author responded Author comments - Fotios Loupakis
2 May 2011 Reviewed Reviewer Report - Chris Garrett
31 May 2011 Reviewed Reviewer Report - W. Charles Conway
Resubmission - Version 6
10 Jun 2011 Submitted Manuscript version 6
Publishing
14 Jun 2011 Editorially accepted
14 Jun 2011 Article published 10.1186/1471-2407-11-247

You can find further information about peer review here.

Back to article page